
The global market for Bio-Layer Interferometry (BLI) Service was valued at US$ 337 million in the year 2024 and is projected to reach a revised size of US$ 478 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Bio-Layer Interferometry (BLI) Service measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
The Bio - Layer Interferometry (BLI) service industry is experiencing rapid growth and presents several notable trends. Technologically, continuous innovation is a key trend. Manufacturers are dedicated to enhancing the sensitivity, throughput, and usability of BLI systems. For example, the next - generation BLI technology (NGB) has been introduced to meet the growing and diverse market demands. BLI is also being increasingly integrated with other technologies to provide more comprehensive and accurate analysis. The application scenarios of BLI are constantly expanding. It is not only widely used in the development of small - molecule drugs, antibody drugs, and protein drugs but also in emerging fields such as vaccine research and development, AAV, and LNP research. In addition, BLI is playing an important role in personalized medicine, enabling the analysis of specific patient responses at the molecular level. Moreover, with the continuous deepening of basic life science research and the development of biopharmaceuticals, as well as the increasing emphasis on biopharmaceuticals, the demand for BLI services in pharmaceutical research laboratories, contract research organizations (CROs), and biotechnology companies is surging.
This report aims to provide a comprehensive presentation of the global market for Bio-Layer Interferometry (BLI) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Layer Interferometry (BLI) Service.
The Bio-Layer Interferometry (BLI) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio-Layer Interferometry (BLI) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-Layer Interferometry (BLI) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ichor Life Sciences, Inc
Creative BioMart
GenScript
Rockland Immunochemicals
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
KMD Bioscience Co., Ltd
2bind GmbH
Sino Biological, Inc
Segment by Type
General Sensors
Capture Sensors
Antibody Sensors
Others
Segment by Application
Affinity and Kinetic Analysis
Pharmaceutical Assay Development
Protein Concentration Measurement
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-Layer Interferometry (BLI) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio-Layer Interferometry (BLI) Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Sensors
1.2.3 Capture Sensors
1.2.4 Antibody Sensors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bio-Layer Interferometry (BLI) Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Affinity and Kinetic Analysis
1.3.3 Pharmaceutical Assay Development
1.3.4 Protein Concentration Measurement
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-Layer Interferometry (BLI) Service Market Perspective (2020-2031)
2.2 Global Bio-Layer Interferometry (BLI) Service Growth Trends by Region
2.2.1 Global Bio-Layer Interferometry (BLI) Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bio-Layer Interferometry (BLI) Service Historic Market Size by Region (2020-2025)
2.2.3 Bio-Layer Interferometry (BLI) Service Forecasted Market Size by Region (2026-2031)
2.3 Bio-Layer Interferometry (BLI) Service Market Dynamics
2.3.1 Bio-Layer Interferometry (BLI) Service Industry Trends
2.3.2 Bio-Layer Interferometry (BLI) Service Market Drivers
2.3.3 Bio-Layer Interferometry (BLI) Service Market Challenges
2.3.4 Bio-Layer Interferometry (BLI) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio-Layer Interferometry (BLI) Service Players by Revenue
3.1.1 Global Top Bio-Layer Interferometry (BLI) Service Players by Revenue (2020-2025)
3.1.2 Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Bio-Layer Interferometry (BLI) Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bio-Layer Interferometry (BLI) Service Revenue
3.4 Global Bio-Layer Interferometry (BLI) Service Market Concentration Ratio
3.4.1 Global Bio-Layer Interferometry (BLI) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio-Layer Interferometry (BLI) Service Revenue in 2024
3.5 Global Key Players of Bio-Layer Interferometry (BLI) Service Head office and Area Served
3.6 Global Key Players of Bio-Layer Interferometry (BLI) Service, Product and Application
3.7 Global Key Players of Bio-Layer Interferometry (BLI) Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio-Layer Interferometry (BLI) Service Breakdown Data by Type
4.1 Global Bio-Layer Interferometry (BLI) Service Historic Market Size by Type (2020-2025)
4.2 Global Bio-Layer Interferometry (BLI) Service Forecasted Market Size by Type (2026-2031)
5 Bio-Layer Interferometry (BLI) Service Breakdown Data by Application
5.1 Global Bio-Layer Interferometry (BLI) Service Historic Market Size by Application (2020-2025)
5.2 Global Bio-Layer Interferometry (BLI) Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bio-Layer Interferometry (BLI) Service Market Size (2020-2031)
6.2 North America Bio-Layer Interferometry (BLI) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bio-Layer Interferometry (BLI) Service Market Size by Country (2020-2025)
6.4 North America Bio-Layer Interferometry (BLI) Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio-Layer Interferometry (BLI) Service Market Size (2020-2031)
7.2 Europe Bio-Layer Interferometry (BLI) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bio-Layer Interferometry (BLI) Service Market Size by Country (2020-2025)
7.4 Europe Bio-Layer Interferometry (BLI) Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio-Layer Interferometry (BLI) Service Market Size (2020-2031)
8.2 Asia-Pacific Bio-Layer Interferometry (BLI) Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bio-Layer Interferometry (BLI) Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Bio-Layer Interferometry (BLI) Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio-Layer Interferometry (BLI) Service Market Size (2020-2031)
9.2 Latin America Bio-Layer Interferometry (BLI) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bio-Layer Interferometry (BLI) Service Market Size by Country (2020-2025)
9.4 Latin America Bio-Layer Interferometry (BLI) Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio-Layer Interferometry (BLI) Service Market Size (2020-2031)
10.2 Middle East & Africa Bio-Layer Interferometry (BLI) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bio-Layer Interferometry (BLI) Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Bio-Layer Interferometry (BLI) Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ichor Life Sciences, Inc
11.1.1 Ichor Life Sciences, Inc Company Details
11.1.2 Ichor Life Sciences, Inc Business Overview
11.1.3 Ichor Life Sciences, Inc Bio-Layer Interferometry (BLI) Service Introduction
11.1.4 Ichor Life Sciences, Inc Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.1.5 Ichor Life Sciences, Inc Recent Development
11.2 Creative BioMart
11.2.1 Creative BioMart Company Details
11.2.2 Creative BioMart Business Overview
11.2.3 Creative BioMart Bio-Layer Interferometry (BLI) Service Introduction
11.2.4 Creative BioMart Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.2.5 Creative BioMart Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Bio-Layer Interferometry (BLI) Service Introduction
11.3.4 GenScript Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.3.5 GenScript Recent Development
11.4 Rockland Immunochemicals
11.4.1 Rockland Immunochemicals Company Details
11.4.2 Rockland Immunochemicals Business Overview
11.4.3 Rockland Immunochemicals Bio-Layer Interferometry (BLI) Service Introduction
11.4.4 Rockland Immunochemicals Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.4.5 Rockland Immunochemicals Recent Development
11.5 BPS Bioscience, Inc
11.5.1 BPS Bioscience, Inc Company Details
11.5.2 BPS Bioscience, Inc Business Overview
11.5.3 BPS Bioscience, Inc Bio-Layer Interferometry (BLI) Service Introduction
11.5.4 BPS Bioscience, Inc Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.5.5 BPS Bioscience, Inc Recent Development
11.6 Creative Proteomics
11.6.1 Creative Proteomics Company Details
11.6.2 Creative Proteomics Business Overview
11.6.3 Creative Proteomics Bio-Layer Interferometry (BLI) Service Introduction
11.6.4 Creative Proteomics Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.6.5 Creative Proteomics Recent Development
11.7 Creative Biostructure
11.7.1 Creative Biostructure Company Details
11.7.2 Creative Biostructure Business Overview
11.7.3 Creative Biostructure Bio-Layer Interferometry (BLI) Service Introduction
11.7.4 Creative Biostructure Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.7.5 Creative Biostructure Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Bio-Layer Interferometry (BLI) Service Introduction
11.8.4 Profacgen Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.8.5 Profacgen Recent Development
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Details
11.9.2 Creative Biolabs Business Overview
11.9.3 Creative Biolabs Bio-Layer Interferometry (BLI) Service Introduction
11.9.4 Creative Biolabs Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.9.5 Creative Biolabs Recent Development
11.10 KMD Bioscience Co., Ltd
11.10.1 KMD Bioscience Co., Ltd Company Details
11.10.2 KMD Bioscience Co., Ltd Business Overview
11.10.3 KMD Bioscience Co., Ltd Bio-Layer Interferometry (BLI) Service Introduction
11.10.4 KMD Bioscience Co., Ltd Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.10.5 KMD Bioscience Co., Ltd Recent Development
11.11 2bind GmbH
11.11.1 2bind GmbH Company Details
11.11.2 2bind GmbH Business Overview
11.11.3 2bind GmbH Bio-Layer Interferometry (BLI) Service Introduction
11.11.4 2bind GmbH Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.11.5 2bind GmbH Recent Development
11.12 Sino Biological, Inc
11.12.1 Sino Biological, Inc Company Details
11.12.2 Sino Biological, Inc Business Overview
11.12.3 Sino Biological, Inc Bio-Layer Interferometry (BLI) Service Introduction
11.12.4 Sino Biological, Inc Revenue in Bio-Layer Interferometry (BLI) Service Business (2020-2025)
11.12.5 Sino Biological, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Ichor Life Sciences, Inc
Creative BioMart
GenScript
Rockland Immunochemicals
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
KMD Bioscience Co., Ltd
2bind GmbH
Sino Biological, Inc
Ìý
Ìý
*If Applicable.
